Bayer

Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case
Fierce Pharma
Tue, 07/25/23 - 11:56 am
Bayer
earnings
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
TV ads
DTC advertising
Bayer
AbbVie
Bristol Myers Squibb
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Fierce Biotech
Wed, 06/28/23 - 10:05 am
Bayer
Parkinson's Disease
clinical trials
cell therapy
bemdaneprocel
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Mon, 06/12/23 - 11:22 pm
Bayer
oncology
M&A
Bayer licenses lipid nanoparticle tech for gene therapy
BioProcess International
Wed, 06/7/23 - 10:17 am
Bayer
Acuitas Therapeutics
gene editing
Bayer launches precision health unit in latest digital health venture
BioPharma Dive
Fri, 06/2/23 - 10:12 am
Bayer
consumer health
digital health
precision health
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Thu, 06/1/23 - 06:43 pm
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Fierce Biotech
Wed, 05/24/23 - 10:23 am
Bayer
business development
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Tue, 05/23/23 - 06:20 pm
Astellas
Iveric Bio
Bayer
Amgen
M&A
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
FDA
drug approvals
accelerated approvals
AbbVie
AstraZeneca
Bayer
Bristol Myers Squibb
JNJ
Merck
Merck KGaA
Novartis
Pfizer
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
BioSpace
Wed, 05/10/23 - 10:04 am
Bayer
Bicycle Therapeutics
drug development
radiopharmaceuticals
Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Amgen
Regeneron Pharmaceuticals
Sanofi
Supreme Court
patents
Pfizer
Bayer
Roche
Genentech
AstraZeneca
JNJ
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
R&D
Amgen
Bayer
Biogen
Gilead Sciences
Merck KGaA
Moderna Therapeutics
Novo Nordisk
Regeneron Pharmaceuticals
UCB
Vertex Pharmaceuticals
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
Bayer's incoming CEO Anderson won't rule out consumer, agriculture spinoffs: report
Fierce Pharma
Wed, 04/5/23 - 12:00 pm
Bayer
Bill Anderson
Pharma CEOs
spinoffs
consumer health
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Tue, 03/14/23 - 06:22 pm
Bayer
diabetes
chronic kidney disease
healthcare providers
physicians
Bayer Plans to Double Down on US Pharma R&D in 2023
BioSpace
Thu, 03/9/23 - 10:07 am
Bayer
R&D
Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023
Fierce Pharma
Tue, 02/28/23 - 10:41 pm
Bayer
earnings
Eylea
Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup
Fierce Pharma
Mon, 02/13/23 - 09:56 pm
Bayer
Roche
Werner Baumann
restructuring

Pages